Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Calculate exactly how many units of Tesamorelin + Ipamorelin to draw on your syringe. Pre-filled with standard defaults.
Draw on your syringe
240
units
(2.400 mL)
100.0% of syringe capacity
Concentration
2,500
mcg/mL
Dose volume
2.400
mL
Doses per vial
0
doses
Cost per dose
---
enter price
Total mcg in vial = 5 mg x 1000 = 5,000 mcg
Concentration = 5,000 mcg / 2 mL = 2,500 mcg/mL
Dose volume = 6000 mcg / 2,500 mcg/mL = 2.4000 mL
Units to draw = 2.4000 mL x 100 units/mL = 240 units
Doses per vial = 5,000 mcg / 6000 mcg = 0.83 doses
Want the full Disclosed Trust Index?
Create a free account to unlock vendor trust scores, the COA scanner, the Forgery Map, and lot lookup across the corpus.
Create a free accountPre-mixed blend of Tesamorelin (a stabilized GHRH(1-44) analog) and Ipamorelin (a selective ghrelin-receptor agonist). Tesamorelin is FDA-approved as Egrifta for HIV-associated lipodystrophy; Ipamorelin is not FDA-approved. The blend itself is NOT clinically validated — no controlled trial has tested Tesamorelin co-administered with Ipamorelin. Evidence is inferred from the individual components.
Common vial size
5
mg
Typical BAC water
2
mL
Dose range
6000–12000
mcg
Default dose
6000
mcg
Store refrigerated (2-8°C). Once reconstituted, use within 28 days.
Disclosed Labs